vimarsana.com

Page 4 - குமிழ்கள் ஆஸ்திரேலியா லிமிடெட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Top brokers name 3 ASX shares to sell next week

Morgans reveals that its analysts have downgraded this plumbing parts company’s shares to a  reduce rating with a price target of $11.45. According to the note, the broker made the move after reducing its earnings estimates to reflect a stronger Australian dollar. In addition to this, the broker thought that its valuation was getting stretched after a strong gain over the last few months. The Reece share price was trading at $16.01 at Friday’s close. Where to invest $1,000 right now When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.

3 reasons why the Bubs (ASX:BUB) share price could be a buy

3 reasons why the Bubs (ASX:BUB) share price could be a buy Tristan Harrison | January 29, 2021 7:00am | More on: Bubs Australia Ltd (ASX: BUB) at today’s share price. What is Bubs? Bubs is primarily an infant formula business that sells products derived from goat milk. It also sells organic, gross-fed cow’s milk infant formula ranges, organic baby food, cereals and toddler snacks. The company also recently launched ‘Vita Bubs’, which is a range of infant and children’s vitamin and mineral supplements formulated with goat milk. It also says it’s the leading producer of goat dairy products in Australia with exclusive milk supply from the largest milking goat herds in the country.

Here s why the Bubs (ASX:BUB) share price is surging 10% higher

Bubs Australia Ltd(ASX: BUB) share price is surging notably higher on Thursday. At the time of writing, the infant formula company’s shares are up 10% to 67 cents. Why is the Bubs share price surging higher? The Bubs share price is on the move today following the release of its second quarter update. For the three months ended 31 December, Bubs reported a 12% decline in gross revenue to $12.8 million. This was despite the company reporting a 34% increase in China cross border ecommerce (CBEC) sales and strong sales growth in Australian supermarkets compared to the same period last year. In respect to supermarket sales, management notes that Bubs is the fastest growing infant formula manufacturer across

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.